Christopher Yea sold $905K of KalVista Pharmaceuticals (KALV)

Executed May 27, disclosed May 29, 2 days later.

Value, as filed

$905K

33,800 sh × $26.78

Executed

May 27

the trade date, as filed

Disclosed

May 29

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CY Christopher Yea CHIEF DEVELOPMENT OFFICER profile →

Christopher Yea (CHIEF DEVELOPMENT OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in KALV. The largest single filing was $905K of KALV (33,800 sh × $26.78, as filed), executed May 27.

The name

KALV KALV KALV · 19 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Christopher Yea in KALV

KALVSALE KalVista Pharmaceuticals, Inc. $475K
30,250 sh × $15.69
Exec Jul 9 2025
Filed Jul 10 2025 · 5:30 PM ET